Sulodexide for limb salvage in refractory diabetic foot ulcer with arteriosclerosis obliterans: a case report
Authors:
Open Access
- 12 February 2026
- journal article
- case report
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1756228
Abstract
Background: Patients with diabetic foot ulcers (DFU) remain at substantial risk for impaired wound healing, even following successful revascularization. This clinical challenge is often associated with underlying microcirculatory dysfunction, highlighting a critical unmet need for effective intervention strategies. Case description: A 77-year-old female patient was suffering from severe DFU on her right foot, with infected wound, complicated by arteriosclerosis obliterans of the lower limbs. She underwent surgical debridement and angiographically and hemodynamically successful endovascular angioplasty. Despite these interventions and restored macrovascular perfusion, the wound exhibited continuously deterioration, and the patient was at imminent risk of minor amputation. Therefore, persistent microcirculatory dysfunction was considered a major contributing factor to the poor healing response, prompting the initiation of a salvage regimen with intravenous Sulodexide (600 LSU/day). Following a 51-day Sulodexide treatment, complete wound healing was achieved and the patient was discharged. Conclusion: This case report suggests that highly selected DFU patients unresponsive to standard therapies including successful revascularization, Sulodexide may be a plausible salvage or adjunctive therapeutic option. This observation is strictly hypothesis-generating and its potential role warrants investigation in future prospective clinical trials.Keywords
This publication has 18 references indexed in Scilit:
- Advances in biomaterials and regenerative medicine for diabetic foot ulcer therapyAgeing Research Reviews, 2025
- Retrospective analysis of the effectiveness and safety of sulodexide for venous thromboembolism prevention in neurosurgical patientsNeurosurgical Review, 2025
- Practical guidelines on the prevention and management of diabetes‐related foot disease (IWGDF 2023 update)Diabetes/Metabolism Research and Reviews, 2023
- Definitions and criteria for diabetic foot diseaseDiabetes/Metabolism Research and Reviews, 2020
- Diabetic Foot Ulcers and Their RecurrenceNew England Journal of Medicine, 2017
- The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI)Journal of Vascular Surgery, 2014
- Endothelial dysfunction in (pre)diabetes: Characteristics, causative mechanisms and pathogenic role in type 2 diabetesReviews in Endocrine and Metabolic Disorders, 2013
- Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled studyEuropean Heart Journal, 2002
- The effect of insulin and sulodexide (Vessel Due F) on diabetic foot syndromeJournal of Diabetes and its Complications, 2001
- Antithrombotic and thrombolytic activity of sulodexide in ratsInternational Journal of Clinical and Laboratory Research, 1992